The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reasons for refusal of or ineligibility for radical cystectomy (RC) in patients (Pts) with bacillus Calmette-Guérin (BCG)–unresponsive high-risk non–muscle-invasive bladder cancer (HR NMIBC) from the SunRISe-1 study.
 
Joseph M Jacob
Consulting or Advisory Role - Janssen; Photocure
Speakers' Bureau - Urogen pharma
 
Félix Guerrero-Ramos
Honoraria - Combat Medical; Janssen; Pfizer
Consulting or Advisory Role - Combat Medical; Janssen; Pfizer; Roche
Travel, Accommodations, Expenses - Combat Medical; Janssen; Pfizer
 
Evanguelos Xylinas
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; MSD; Pfizer
Travel, Accommodations, Expenses - IPSEN,; Janssen
 
Giuseppe Simone
No Relationships to Disclose
 
Yair Lotan
Stock and Other Ownership Interests - C2i genomics; CAPs medical; Nanorobotics; Phinomics; Uroviu; Vessi Medical; Virtuoso Therapeutics
Consulting or Advisory Role - Abbvie; Ambu; AstraZeneca; Aura Biosciences; BMS; C2i genomics; caps medical; Cleveland Diagnostics; Convergent Genomics; Fergene; Merck; Nanogen Biopharmaceutical; Nanorobotics; Nucleix; pacific edge; phinomics; Photocure; Seagen; Stimit; Urogen pharma; uroviu; verity pharmaceuticals; Vessi Medical; virtuoso surgical; Xcures
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); storz (Inst)
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Foundation Medicine; Janssen Oncology; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen Oncology; Merck; Pfizer
 
Harm Arentsen
Research Funding - Janssen
Travel, Accommodations, Expenses - European Association of Urology
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Girish S. Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; BioSyent; Knight Pharmaceuticals; Tersera
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Theralase; Verity Pharmaceuticals
 
Manish Patel
Honoraria - Astellas Pharma; AstraZeneca; Ferring; Janssen
 
David J Cahn
Consulting or Advisory Role - AstraZeneca; Janssen
 
Jong Kil Nam
No Relationships to Disclose
 
Martin Boegemann
Employment - Janssen; Janssen
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; Janssen-Cilag
 
Shalaka Hampras
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Katherine Stromberg
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Jason L. Martin
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Abhijit Shulka
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Hussein Sweiti
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Michiel Simon Van Der Heijden
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - 4SC (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis; Roche